Apellis PharmaceuticalsAPLS 
$35.630.28%24h
0.28%24h
Global rank3154
Market cap$4.22B
Change 7d-10.18%
YTD Performance-40.51%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Apellis Pharmaceuticals (APLS)
As of November 2024, Apellis Pharmaceuticals has a market cap of $4.22B. This makes Apellis Pharmaceuticals the world's 3154th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Apellis Pharmaceuticals from 2017 to 2024
-
Value:-
Market cap history of Apellis Pharmaceuticals from 2017 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $8.01B | 12.96% |
| 2023 | $7.09B | 15.76% |
| 2022 | $6.13B | 9.37% |
| 2021 | $5.60B | -17.34% |
| 2020 | $6.78B | 86.81% |
| 2019 | $3.63B | 132.15% |
| 2018 | $1.56B | -39.22% |
| 2017 | $2.57B | - |
APLS Market Cap Today is $4.22B 0.28% - 13 Nov 2024
View largest stocks by market cap 
